Eugene

[email protected]

LATEST

Lonza, Proteon Therapeutics Extend API Biomfg Pact
By

By
Lonza has extended its contract with Proteon Therapeutics, a Waltham, Massachusetts-headquartered company developing therapeutics for kidney and vascular diseases, to commercially supply the active pharmaceutical ingredient (API) of Proteon’s lead…

AstraZeneca, Merck & Co., and Astellas Lead Drug Approval News
By

By
A roundup of the latest drug approvals, including from the pharmaceutical majors, featuring news from Otsuka Pharmaceutical. Editor’s Note: This article was updated on a continuous basis for news announced from…

Roche Leads Pipeline News
By

By
A roundup of the latest market developments from the pipelines of the pharmaceutical majors, featuring news from Roche. Editor’s Note: This article was updated on a continuous basis for news…

Melinta Therapeutics, CARB-X Partner in Antibiotics
By

By
Melinta Therapeutics, a New Haven, Connecticut-based biopharmaceutical company developing antibiotics, has partnered with CARB-X, a Boston, Massachusetts-based partnership organization focused on early-development antibacterial research and development, to support developing Melinta’s…

Valeant To Change Company Name to Bausch Health Companies
By

By
Valeant Pharmaceuticals International plans to change its name to Bausch Health Companies, effective July 2018. The new name is taken from its subsidiary, Bausch + Lomb, an eye-care company, which…

Takeda and Shire Come to Terms on Proposed $62-Billion Acquisition of Shire by Takeda
By

By
Takeda Pharmaceutical Company and Shire have come to terms for a proposed acquisition of Shire by Takeda for approximately $62 billion. Takeda first disclosed an acquisition proposal for Shire in…

Sterling Pharma To Invest $8 Million To Expand API Pilot Plant
By

By
Sterling Pharma Solutions, a Dudley, UK-headquartered contract development and manufacturing organization, is investing £6 million ($8 million) to expand its pilot plant at its UK site to increase capacity by…

Lonza To Invest in Mid-Scale Biomfg and Cell-Therapy Capacity
By

By
Lonza is investing in mid-scale mammalian cell biomanufacturing capacity and new cell-therapy suites at its site in Portsmouth, New Hampshire.   Lonza plans to install multiple 6,000-liter bioreactors at the…

Neopharma, ASKA Pharma Form JV for Drug-Product Mfg Facility in India
By

By
Omnicare Drugs India Pvt Ltd, a subsidiary of Neopharma, a pharmaceutical company headquartered in Abu Dhabi, United Arab Emirates, and ASKA Pharmaceuticals, a Tokyo-Japan headquartered company, have agreed to form…

AstraZeneca in Stem-Cell Cardiovascular Therapy Pact
By

By
AstraZeneca has partnered with Procella Therapeutics and Smartwise, wholly owned subsidiaries of SWIB Holdings, a Stockholm, Sweden-based biotech and medical-device investment company, to develop ways of regenerating parts of the…